bazedoxifene/conjugated estrogens combination tablet

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
32
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Postmenopause

Conditions

Postmenopause

Trial Timeline

Aug 1, 2006 โ†’ Aug 1, 2006

About bazedoxifene/conjugated estrogens combination tablet

bazedoxifene/conjugated estrogens combination tablet is a phase 1 stage product being developed by Pfizer for Postmenopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00367536. Target conditions include Postmenopause.

Hype Score Breakdown

Clinical
10
Activity
5
Company
9
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT00367536Phase 1Completed